3Suppliers
1Customers
2Debt Items
20Related Chains
Crescent Biopharma, Inc. Suppliers
| Ticker | Name | Confidence | Evidence |
|---|
| PARAGON |
PARAGON |
90%
|
The Company’s ongoing research and development activities conducted to date by vendors, including the Company’s related party Paragon |
| CMOS |
CMOS |
80%
|
contract manufacturing organizations ("CMOs") |
| CROS |
CROS |
80%
|
contract research organizations ("CROs") |
Crescent Biopharma, Inc. Customers
| Ticker | Name | Confidence | Evidence |
|---|
| KELUN |
KELUN |
90%
|
The Kelun CR-001 License Agreement includes the provision of the initial supply of CR-001 drug product by the Company |
Crescent Biopharma, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| CBIO-DEBT |
Debt stack $1.5M |
90%
|
Market cache reports total debt of $1.5M. |
| CBIO-DEBT-8500 |
Warrants outstanding: 553868 |
90%
|
xbrl warrant detail from xbrl 2025-12-31. |
Crescent Biopharma, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Crescent Biopharma, Inc..
Crescent Biopharma, Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| CBIO-OWNER-FMR-LLC |
FMR LLC |
90%
|
13F overlay lists FMR LLC as top holder; 60 tracked holders. |
Crescent Biopharma, Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
100.00 |
2 |
|
| SVA |
Sinovac Biotech Ltd. |
100.00 |
2 |
|
| ATOS |
Atossa Therapeutics, Inc. |
100.00 |
2 |
|
| CYTOF |
Altamira Therapeutics Ltd. |
100.00 |
2 |
|
| CALC |
CalciMedica, Inc. |
100.00 |
2 |
|
| ANL |
Adlai Nortye Ltd. |
100.00 |
2 |
|
| BLRX |
BioLineRx Ltd. |
100.00 |
2 |
|
| AUTL |
Autolus Therapeutics plc |
100.00 |
2 |
|
| BIOA |
BioAge Labs, Inc. |
100.00 |
2 |
|
| CYTK |
Cytokinetics, Incorporated |
100.00 |
2 |
|
| CTMX |
CytomX Therapeutics, Inc. |
100.00 |
2 |
|
| WHWK |
Whitehawk Therapeutics, Inc. |
100.00 |
2 |
|
| CCEP |
Coca-Cola Europacific Partners PLC |
100.00 |
2 |
|
| DSGN |
Design Therapeutics, Inc. |
100.00 |
2 |
|
| AZN |
AstraZeneca PLC |
100.00 |
2 |
|
| ANRO |
Alto Neuroscience, Inc. |
100.00 |
2 |
|
| ALXO |
ALX Oncology Holdings Inc. |
100.00 |
2 |
|
| DBVTF |
DBV TECHNOLOGIES |
100.00 |
2 |
|
| EDIT |
Editas Medicine, Inc. |
100.00 |
2 |
|
| GRDX |
GridAI Technologies Corp. |
100.00 |
2 |
|
